Bitscopic Commercializes PraediGene to Automate Genomic Variant Interpretation and Make Clinical Genomics Programs Inspection-Ready
Bitscopic Commercializes PraediGene to Automate Genomic Variant Interpretation and Make Clinical Genomics Programs Inspection-Ready SEATTLE, WA — [February 25, 2026] – Bitscopic today announced the commercialization of PraediGene, a clinical-grade platform designed to help laboratories scale genomic testing with reproducible variant interpretation, audit-ready decision trails, and standardized reporting across clinical domains. PraediGene has served as […]
Bitscopic’s Case for Data-First AI
Bitscopic’s Case for Data-First AI Written by Eugene Geis, Ph.D., Director of Data Science and Research Data-first AI is a simple premise: our models will never perform better than the data they leverage. In safety-critical domains like healthcare, clinical genomics, and bioinformatics, dirty data is dangerous. Leaders like Andrew Ng have argued for “data-centric AI,” […]
Sepsis Patients Monitoring with PraediAlert
Sepsis Patients Monitoring with PraediAlert New tool for pharmacists! We’re excited to announce the launch of the Sepsis Patients Monitoring Module, a new tool designed specifically to help pharmacists closely monitor patients who meet Systemic Inflammatory Response Syndrome (SIRS) criteria. This module ensures timely reassessment and appropriate care coordination to meet CMS sepsis standards. Who […]
PraediAlert Hemodialysis Monitoring Module
The PraediAlert Hemodialysis Monitoring Module: Essential Monitoring for Infection Preventionists Infection Preventionists (IPs) face the critical challenge of preventing healthcare-associated infections (HAIs) in high-risk patient populations, such as those undergoing hemodialysis. These patients are especially vulnerable to bloodstream and access site infections, which contribute significantly to morbidity and mortality. The PraediAlert Hemodialysis Monitoring Module is […]
What Every Hospital CIO Should Know Before Choosing a Genomics Platform
What Every Hospital CIO Should Know Before Choosing a Genomics Platform Genomics is no longer a “pilot project.” It has become infrastructure. As precision medicine programs mature, hospital CIOs are being asked to evaluate, and often purchase, platforms that support sequencing, interpretation, and reporting at clinical scale. But genomics is not just another dataset. It […]
Pharmacogenomics and Polypharmacy: Why Reporting Speed Matters
Pharmacogenomics and Polypharmacy: Why Reporting Speed Matters Polypharmacy isn’t rare. For many older adults, and especially within Veteran populations, it’s the norm. Managing multiple medications across multiple prescribers is already complex. Add pharmacogenomics, and the value is clear – but only if the timing works. A PGx result that arrives after the prescription doesn’t help. […]
Bitscopic appoints Kelly Echevarria, Pharm.D., BCIDP to advance VA antimicrobial stewardship with PraediAlert
Bitscopic appoints Kelly Echevarria, Pharm.D., BCIDP to advance VA antimicrobial stewardship with PraediAlert Bitscopic today announced the appointment of Kelly L. Echevarria, Pharm.D., BCIDP as National Program Expert for Clinical Stewardship Solutions for PraediAlert, the company’s clinical surveillance and antimicrobial stewardship platform. Echevarria will support VA Medical Centers in operationalizing reliable antimicrobial stewardship workflows. She […]
How to Integrate Genomic Reports into Your EHR (Without Breaking Your Workflow)
How to Integrate Genomic Reports into Your EHR (Without Breaking Your Workflow) EHRs weren’t built for genomics. But clinicians need genomic data where they already work, inside the system, not outside it. As more health systems roll out precision medicine initiatives, the challenge isn’t just generating clean genomic reports. It’s delivering them in the right […]
Building a Scalable PGx Program: 5 Workflow Pitfalls to Avoid
Building a Scalable PGx Program: 5 Workflow Pitfalls to Avoid Pharmacogenomics (PGx) holds enormous promise, but implementing it at scale is anything but straightforward. We’ve seen many PGx programs start strong and then stall. Not because of clinical resistance, but because of operational friction. From inconsistent reporting to unclear ownership, the obstacles often aren’t scientific […]
The FDA Backpedals on LDTs: What It Means for Clinical Labs
The FDA Backpedals on LDTs: What It Means for Clinical Labs For more than a decade, labs have operated under a cloud of uncertainty around who truly regulates laboratory developed tests (LDTs). The FDA’s now-rescinded 2024 final rule would have classified LDTs as medical devices, forcing hospital and health system labs into an additional layer […]